Collaborative R&D partnerships can be established between pharmas, or an established pharma and a biotech. While the...
Targeted protein degraders (TPD) are rapidly moving from niche science to mainstream drug development, with few therapie...
MS Pharma has officially opened the first biologics manufacturing plant in the Middle East, strategically located i...
A major milestone in Evonik's global catalyst strategy has been achieved with the opening of its new alkoxides productio...
To meet the growing demand for temperature-sensitive pharmaceutical logistics, DHL Global Forwarding continues to enhanc...
Please highlight Taiwan’s wellness and health-tech ambitions for the Indian market? Taiwan’s wellness and h...
Nippon Kayaku, Formiica Pharmaceuticals and CBC Co. have agreed to jointly establish a joint venture (JV) for the purpos...
Abbott, the global healthcare leader, has received regulatory approval for the first denosumab biosimilar in Thaila...
Genentech, a member of the Roche Group, broke ground on its newest US manufacturing site in Holly Springs, North Carolin...
Japan's Meiji Seika Pharma has announced that its local subsidiary, Thai Meiji Pharmaceutical has received regulatory ap...
Sharing his perspectives with BioSpectrum Asia, Narayana Rao Rapolu, Senior Vice President, Global Bioprocessing...
In furtherance to the country’s initiatives towards strengthening the pharma and healthcare industry, the Philippi...
Belgium's Hyloris Pharmaceuticals SA, has announced that an exclusive license and supply agreement has been signed with ...
Johnson & Johnson has announced that it will increase its presence in North Carolina with a 160,000+ square foo...
China's BioDlink has announced that its Bevacizumab Injection has obtained marketing authorisation from&n...
Paris-based Nicox SA, an international ophthalmology company, has announced the signing of a major new agreement concern...
GC Biopharma, a South Korean biopharmaceutical company, has signed a Memorandum of Understanding (MoU) with the Thai Red...
Eisai Co. has announced that the in-house discovered and developed orexin receptor antagonist DAYVIGO® (brand name i...
(Left to Right) Wallace Lin; Claire Skentelbery; George Hara; Johnsee Lee; Liu Lee-Cheng; Dr. Kelly Seagraves The BIO A...
China-based Kexing Biopharm has entered into a comprehensive strategic partnership with IQVIA, a global leader...
Japan-based Solasia Pharma has entered into a licensing agreement with Firebird Biologics (headquartered in Singapore) g...
China-based Fosun Pharma has signed a license agreement with Expedition Therapeutics Inc. to grant the rights to de...
If there’s anything good to come from the tariff turmoil, it is that countries have rediscovered the importance of...
The Ministry of Health and Prevention (MoHAP) in the UAE has signed a Memorandum of Understanding (MoU) with Sanofi...
Astria Therapeutics, Inc. a US-based biopharmaceutical company, has exclusively licensed development and commercial...
